This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Balfour Beatty (BBY) - The construction company announces FY underlying profits more than double with improvements across the board, paving the way for a 22% increase to the FY dividend.
Hikma Pharmaceuticals (HIK) - Days after receiving a fresh setback from teh FDA, the drugmaker announces it has swung to pretax loss after a US generics impairment. Revenues were flat, while the dividend of 23c comes in just ahead of the 22c previous.
Morrisons (MRW) - The supermarket chain announces FY group like-for-like sales ex-fuel rose 2.8% (Q4 retail slower, wholesale faster), while underlying pre-tax profit improved 11%. This allows management to announce a 4p special dividend, raising the full payout by 86%. Encouragingly, the pension surplus more than doubles, while net debt is below £1bn. Management notes it is on track for wholesale supply sales and profits targets.
Prudential (PRU) - The UK's largest insurer is to split its business, separating its UK business from the US, Asian and African segment. Management hopes the two new entities, Prudential Plc (US & Asia) and M&G Prudential (UK) will have greater control of capital allocation.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ANTOFAGASTA | ANTO | 3.0% | 3.6% | 0.9% |
| GREENCORE GROUP | GNC | -30.3% | -13.2% | -30.3% |
| LEGAL & GENERAL GROUP | LGEN | -2.5% | -0.1% | -2.7% |
| TP ICAP | TCAP | -10.5% | -0.6% | -10.5% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research